西利比宁通过增强线粒体综合体I和II的功能来抑制PM2.5诱导的肝脏甘油三积累
Dexin Li1,2,3,4,5, Jingxin Zhang1,2,3,4,5, Yuxin Jin1,2,3,4,5
1Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing, China.
Frontiers in pharmacology
|October 1, 2024
概括
乳提取物,西利比宁,通过减少甘油三的积累,保护肝脏免受颗粒物 (PM2.5) 的影响. 它增强了线粒体功能,特别是复合II,以减轻PM2.5引起的肝损伤.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 毒理学 毒理学 毒理学
- 线粒体生物学 线粒体生物学
背景情况:
- 乳提取物 (silibinin) 在草药中具有很长的历史,用于保护肝脏.
- 西利比宁对颗粒物质 (PM2.5) 诱导的肝脏脂肪积累的影响尚不清楚.
- 这项研究研究了西利比宁对PM2.5诱导的肝脏内甘油三积累及其机制的影响.
研究的目的:
- 为了确定西利比宁对PM2.5诱导的肝脏内甘油三醇积累的影响.
- 阐明西利比宁对PM2.5毒性的保护作用的潜在机制.
- 探索西利比宁在线粒体功能和氧化应激中的作用.
主要方法:
- 在小鼠和Hep G2细胞中建立了PM2.5诱导的肝脏内甘油三糖积累模型.
- 给药的西利比宁和评估肝/细胞参数,包括甘油三,胆固醇,ROS和炎症/抗氧化因素.
- 利用蛋白质组学,实时PCR和线粒体功能测试来研究机制.
主要成果:
- 暴露于PM2.5增加了肝脏内甘油三,ROS,炎症和酸受体信号,同时降低了抗氧化剂.
- 锡比宁治疗部分或完全逆转了这些PM2.5诱导的变化,保护了肝细胞和动物模型.
- 西利比宁增强了线粒体的氧化酸化,特别是复合II (糖酸脱酶),一个直接的目标.
结论:
- 西利比宁有效地减轻PM2.5诱导的肝脏内甘油三甲酸积累.
- 这种保护作用部分归因于强化的线粒体氧化酸化 (复合物I和II).
- 西利比宁显示出作为治疗PM2.5相关肝损伤的治疗剂的潜力.
更多相关视频
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013
10.6K
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
812
相关概念视频
01:30The Electron Transport Chain
16.3K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.3K
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
581
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
581